ORIONS Money Stocks

[oldberkeley]

DVAX being able to fix the safety issues before the next schedule FDA review has nothing to do with how DVAX will trade. The fact that there is even a 1 in a million chance that it could be approved will cause the usual FDA run-up, It's just the way things are

Exactly, just what I was saying, you and I have discussed this previously and we're in agreement.

Approval is highly unlikely; a run-up is highly likely and a good chance to make money!

OT: You're an experienced, civil poster and value the exchange of ideas. One of the biggest problems on iHub (and other sites) is that as soon as the opposing bear or bull thesis is stated, the other person feels the need to personally attack. Ridiculous.

The major investment firms pay large sums of money precisely to hear both sides before they invest.

Best of luck!